Clinical Trial Update: Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence [Phase 3]

View source ↗

Summary

A Phase 3 trial of topically administered oxybutynin gel for urge urinary incontinence has completed, with results posted in January 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence

Drugs mentioned

• Oxybutynin Topical Gel (oxybutynin topical gel)

Snippet

Sponsor: Antares Pharma Inc. | Conditions: Urge Urinary Incontinence, Urinary Frequency | Phase 3 | Status: COMPLETED | Results posted: 2011-01-19